Clinical Research

Medibiofarma S.L.

Address
Poligono Industrial Mocholi 2 B, Noain C

Sponsor Overview

assignment
3
sponsored trials
science
2
molecules
location_city
3
research centres
public
1
country
person_search
3
investigators

Specializations

Neurology and Huntington’s disease

Medibiofarma S.L. is active in clinical research for Huntington’s disease, with interest in treatments aimed at addressing neurological symptoms and disease-related functional decline.

  • Neurodegenerative disease
  • Movement disorder
  • Symptom management

The sponsor’s neurology portfolio reflects a focus on therapeutic options for patients living with inherited neurodegeneration.

Gastroenterology and Crohn’s disease

Its clinical research also includes Crohn’s disease, with attention to inflammatory bowel disease and complications linked to intestinal narrowing and tissue remodeling.

  • Inflammatory bowel disease
  • Intestinal stenosis
  • Fibrotic complications

These studies place gastrointestinal inflammation and fibrosis among the sponsor’s key therapeutic interests.

Women’s health and primary dysmenorrhea

Medibiofarma S.L. is also involved in research on primary dysmenorrhea, supporting clinical interest in pain conditions affecting women’s reproductive health.

  • Menstrual pain
  • Gynecological disorders
  • Women’s reproductive health

This area highlights a therapeutic focus on managing pain-related gynecological conditions.

Sponsored Trials

Trial Name Country Status
A phase IIa, open label, Single-centre study to assess the initial antifibrotic efficacy, safety, tolerability, pharmacokinetic and pharmacodynamic profile of MBF-118 in Crohn’s disease patients with stenosis.Spain SpainNot Recruiting
Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBF-015 in Huntington's Disease: A Phase IIa Open-Label StudySpain SpainNot Recruiting
Phase I Evaluation of MBF-362 Safety and Tolerability in Healthy Females and Efficacy in Primary Dysmenorrhea PatientsSpain SpainRecruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
2
Exclusive Molecules
out of 2 total (100% not shared with other sponsors)

This sponsor works with 2 molecules, of which 2 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 3 sites collaborated multiple times

This sponsor has worked with 3 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Digestive System Diseases1 trial
    280 other sponsors
  • 2.
    Female Urogenital Diseases and Pregnancy Complications1 trial
    142 other sponsors
  • 3.
    Nervous System Diseases1 trial
    449 other sponsors

Partnered Research Centres

3 centres
location_city
assignment11
Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau
Address
Calle Sant Quinti 77-79, 08041 Barcelona
Learn morearrow_forward
location_city
assignment735
Hospital De La Santa Creu I Sant Pau
Address
Carrer De San Quinti 89, 08041 Barcelona
Learn morearrow_forward
location_city
assignment601
Universidade De Santiago De Compostela
Address
Calle Choupana Da S/n, 15706 Santiago de Compostela
Learn morearrow_forward

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Medibiofarma S.L..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.